Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Lowering certain hormone levels improves treatment for hair loss in young men.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

No treatment showed clear superiority for lichen planopilaris.

Many alpacas have skin diseases, with bacterial infections being the most common.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.

Beard hair extraction improves scalp hair restoration results in East Asian men with severe hair loss.

Topical bimatoprost 0.01% improves eyebrow density and diameter, especially at the tail.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

QR678 Neo is more effective than PRP for hair growth and quality.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Young women were the most common patients at the dermatology clinic.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Hair transplants are better for severe hair loss, while scalp micropigmentation suits those with denser hair.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.